New Insights Into the Role of Interleukin-6 in Human Prostate Cancer

Journal of Urology

Volumn 182, Issue 4 SUPPL., 2009, Pages 1255-1256

  Culig, Zoran ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; BICALUTAMIDE; CNTO 328; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; RETINOBLASTOMA PROTEIN; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA;

CARCINOGENESIS; CELL STRAIN LNCAP; CYTOKINE PRODUCTION; EDITORIAL; HUMAN; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION;

HUMANS; INTERLEUKIN-6; MALE; PROSTATIC NEOPLASMS;

EID: 69749117003     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.07.073     Document Type: Editorial

References (9)

1. Twillie D.A., Eisenberger M.A., Carducci M.A., et al. Interleukin-6: a candidate mediator of human prostate cancer morbidity. Urology 45 (1995) 542
2. Culig Z., Steiner H., Bartsch G., et al. Interleukin-6 regulation of prostate cancer cell growth. J Cell Biochem 95 (2005) 497
3. Spiotto M.T., and Chung T.D. STAT3 mediates IL-6-induced growth inhibition in the human prostate cancer cell line LNCaP. Prostate 42 (2000) 88
4. Chung T.D., Yu J.J., Kong T.A., et al. Interleukin-6 activates phosphotidylinositol-3 kinase, which inhibits apoptosis in human prostate cancer cell lines. Prostate 42 (2000) 1
5. Hobisch A., Eder I.E., Putz T., et al. Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor. Cancer Res 58 (1998) 4640
6. Malinowska K., Neuwirt H., Cavarretta I.T., et al. Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor. Endocr Relat Cancer 16 (2009) 155
7. Neuwirt H., Puhr M., Cavarretta I.T., et al. Suppressor of cytokine signalling-3 is up-regulated by androgen in prostate cancer cell lines and inhibits androgen-mediated proliferation and secretion. Endocr Relat Cancer 14 (2007) 1007
8. Nonn L., Duong D., and Peehl D.M. Chemopreventive anti-inflammatory activities of curcumin and other phytochemicals mediated by MAP kinase phosphatase-5 in prostate cells. Carcinogenesis 28 (2007) 1188
9. Wallner L., Dai J., Escara-Wilke J., et al. Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice. Cancer Res 66 (2006) 3087